Cellular and molecular mechanisms of the human embryonic leads to fetal hemoglobin switch.

C Peschle(Istituto Superiore di Sanità), Marco Presta(University of Brescia), Sergio Ottolenghi(University of Milano-Bicocca), Paola Comi(University of Milan), Giovanni Migliaccio(University of Illinois Chicago), Anna Ritá Migliaccio(Altius Institute for Biomedical Sciences), G Mastroberardino, Barbára Giglioni, G Russo, AM Gianni
PubMed
January 1, 1983
Cited by 2

Related Papers

The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells
|Cell|1993|610
Isolation and characterization of CD146+ multipotent mesenchymal stromal cells
|Experimental Hematology|2008|254
A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis
|Nature Cell Biology|2008|226
Cutting Edge: Extracellular High Mobility Group Box-1 Protein Is a Proangiogenic Cytokine
|The Journal of Immunology|2006|225
Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2
|Blood|2010|205